GoodRx Holdings, Inc. (GDRX) DCF Valuation

GoodRx Holdings, Inc. (GDRX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

GoodRx Holdings, Inc. (GDRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the (GDRX) DCF Calculator! Utilize actual GoodRx financial data, adjust growth predictions and expenses, and observe the immediate effects of these changes on the intrinsic value of (GDRX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 388.2 550.7 745.4 766.6 750.3 896.4 1,071.0 1,279.7 1,529.0 1,826.8
Revenue Growth, % 0 41.85 35.36 2.83 -2.12 19.48 19.48 19.48 19.48 19.48
EBITDA 148.3 -257.1 48.0 68.5 112.9 39.3 47.0 56.1 67.1 80.1
EBITDA, % 38.19 -46.69 6.44 8.94 15.05 4.39 4.39 4.39 4.39 4.39
Depreciation 15.7 22.9 37.6 57.5 107.7 63.0 75.2 89.9 107.4 128.3
Depreciation, % 4.05 4.16 5.05 7.5 14.35 7.02 7.02 7.02 7.02 7.02
EBIT 132.5 -280.0 10.4 11.0 5.3 -23.6 -28.2 -33.7 -40.3 -48.1
EBIT, % 34.14 -50.85 1.39 1.44 0.70109 -2.64 -2.64 -2.64 -2.64 -2.64
Total Cash 26.1 968.7 941.1 757.2 672.3 708.3 846.3 1,011.2 1,208.2 1,443.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 48.1 68.7 126.4 117.1 160.0
Account Receivables, % 12.4 12.48 16.96 15.28 21.33
Inventories .0 2.9 -8.3 .0 .0 -1.1 -1.3 -1.5 -1.8 -2.2
Inventories, % 0.000000258 0.5266 -1.12 0 0 -0.1182 -0.1182 -0.1182 -0.1182 -0.1182
Accounts Payable 7.9 10.3 17.5 17.7 36.3 24.0 28.7 34.2 40.9 48.9
Accounts Payable, % 2.02 1.87 2.35 2.31 4.83 2.68 2.68 2.68 2.68 2.68
Capital Expenditure -5.7 -35.8 -34.5 -55.2 -55.8 -48.8 -58.4 -69.7 -83.3 -99.5
Capital Expenditure, % -1.48 -6.51 -4.62 -7.2 -7.43 -5.45 -5.45 -5.45 -5.45 -5.45
Tax Rate, % 84.04 84.04 84.04 84.04 84.04 84.04 84.04 84.04 84.04 84.04
EBITAT 105.5 -270.9 25.7 15.6 .8 -18.5 -22.1 -26.5 -31.6 -37.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 75.2 -304.9 -10.3 19.0 28.4 3.8 -27.8 -33.2 -39.7 -47.4
WACC, % 9.75 10.12 10.19 10.19 8.36 9.73 9.73 9.73 9.73 9.73
PV UFCF
SUM PV UFCF -102.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -48
Terminal Value -626
Present Terminal Value -394
Enterprise Value -496
Net Debt 39
Equity Value -535
Diluted Shares Outstanding, MM 410
Equity Value Per Share -1.30

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real GDRX financials.
  • Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on GoodRx's valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life GDRX Financials: Pre-filled historical and projected data for GoodRx Holdings, Inc. (GDRX).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate GoodRx’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize GoodRx’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based GDRX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates GoodRx's intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial analysis.

Why Choose This Calculator for GoodRx Holdings, Inc. (GDRX)?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses all in one convenient package.
  • Customizable Inputs: Modify the yellow-highlighted cells to explore various financial scenarios.
  • Detailed Insights: Automatically computes the intrinsic value and Net Present Value for GoodRx Holdings, Inc. (GDRX).
  • Preloaded Data: Access historical and forecasted data for accurate analysis starting points.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on GoodRx Holdings, Inc. (GDRX).

Who Should Use This Product?

  • Investors: Accurately estimate GoodRx Holdings, Inc.’s (GDRX) fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to GoodRx Holdings, Inc. (GDRX).
  • Consultants: Quickly adapt the template for valuation reports tailored for GoodRx Holdings, Inc. (GDRX) clients.
  • Entrepreneurs: Gain insights into financial modeling techniques utilized by leading companies like GoodRx Holdings, Inc. (GDRX).
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies applicable to GoodRx Holdings, Inc. (GDRX).

What the Template Contains

  • Historical Data: Includes GoodRx's past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate GoodRx's intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of GoodRx's financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.